Eli Lilly challenges Roche's antibody patents in US court
This article was originally published in Scrip
Executive Summary
Eli Lilly filed suit in US court challenging patents held by Roche’s Genentech that may affect Lilly’s cancer drug Erbitux (cetuximab).